Liquidia Corporation ( LQDA) - Key Metrics
LQDA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.06 | $0.17 | $0.51 | $0.48 |
| 2025Q3 | $0.63 | -$0.04 | -$0.11 | -$0.12 |
| 2025Q2 | $0.10 | -$0.49 | -$0.46 | -$0.47 |
| 2025Q1 | $0.04 | -$0.45 | -$0.36 | -$0.36 |
LQDA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 51.60 |
| 2025Q3 | ? | -138.92 |
| 2025Q2 | ? | -6.41 |
| 2025Q1 | ? | -8.19 |
LQDA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.51% | ? |
| 2025Q4 | 1.40% | ? |
| 2025Q3 | -0.54% | ? |
| 2025Q2 | -3.80% | ? |
| 2025Q1 | -2.47% | ? |
LQDA
Price: $71.40
52 week price:
Earnings Per Share: 0.17 USD
P/E Ratio: 334.88
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 65756
Market Capitalization: 5.5 billion